Special Cases in Acute Heart Failure Syndromes: Atrial Fibrillation and Wide Complex Tachycardia

Heart Failure Clinics

Volumn 5, Issue 1, 2009, Pages 113-123

  Pang, Peter S ^a   Gheorghiade, Mihai ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Acute heart failure syndromes; Atrial fibrillation; Wide complex tachycardia

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOFETILIDE; DOPAMINE; ESMOLOL; GLYCERYL TRINITRATE; IBUTILIDE; INOTROPIC AGENT; LEVOSIMENDAN; LOOP DIURETIC AGENT; METILDIGOXIN; MILRINON; NESIRITIDE; PLACEBO; PROCAINAMIDE; TEZOSENTAN; UNCLASSIFIED DRUG; VERAPAMIL;

ABSENCE OF SIDE EFFECTS; ACUTE HEART FAILURE; CARDIOGENIC SHOCK; CARDIOVERSION; CLINICAL TRIAL; DEMOGRAPHY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; EARLY INTERVENTION; EMERGENCY WARD; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PATIENT CARE; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; RISK MANAGEMENT; SINUS RHYTHM; TACHYCARDIA; THROMBOEMBOLISM; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ATRIAL FIBRILLATION; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK FACTORS; SHOCK, CARDIOGENIC; TACHYCARDIA; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 56149104762     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2008.08.009     Document Type: Review

References (55)

1. Fonarow G.C., Adams Jr. K.F., Abraham W.T., et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572
2. Fonarow G.C., Heywood J.T., Heidenreich P.A., et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from acute decompensated heart failure national registry (ADHERE). Am Heart J 153 (2007) 1021
3. Fonarow G.C., Stough W.G., Abraham W.T., et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50 (2007) 768
4. Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958
5. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384
6. Gheorghiade M., Filippatos G., De Luca L., et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119 (2006) S3
7. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209
8. ADHERE Scientific Advisory Committee. Acute Decompensated Heart Failure National Registry (ADHERE) Core Module Q1 2006 final cumulative national benchmark report. In: Scios, Inc, 2006.
9. Fonarow G.C. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 Suppl 7 (2003) S21
10. Khand A.U., Rankin A.C., Kaye G.C., et al. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 21 (2000) 614
11. Chicos A.B., and Kadish A.H. Arrhythmia in acute heart failure. In: Mebazaa A., Gheorghiade M., and Zannad F.M. (Eds). Acute heart failure (2008), Springer-Wilson, London
12. Doval H.C., Nul D.R., Grancelli H.O., et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation 94 (1996) 3198
13. Teerlink J.R., Jalaluddin M., Anderson S., et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 101 (2000) 40
14. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 48 (2006) 854
15. Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 12 (2006) 10
16. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154
17. Crijns H.J., Tjeerdsma G., de Kam P.J., et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21 (2000) 1238
18. Efremidis M., Pappas L., Sideris A., et al. Management of atrial fibrillation in patients with heart failure. J Card Fail 14 (2008) 232
19. Folkeringa J.R., Crijns H.J., and Van Veldhuisen D.J. Prognosis of atrial fibrillation in congestive heart failure. Circulation 109 (2004) e11
20. Heist E.K., and Ruskin J.N. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog Cardiovasc Dis 48 (2006) 256
21. Wang T.J., Larson M.G., Levy D., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 (2003) 2920
22. Wasywich C.A., Whalley G.A., Gamble G.D., et al. Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure. Heart Lung Circ 15 (2006) 353
23. Cain M.E. Atrial fibrillation: rhythm or rate control. N Engl J Med 347 (2002) 1822
24. Van Gelder I.C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834
25. Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825
26. Al-Khatib S.M., Shaw L.K., Lee K.L., et al. Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?. Am J Cardiol 94 (2004) 797
27. Kareti K.R., Chiong J.R., Hsu S.S., et al. Congestive heart failure and atrial fibrillation: rhythm versus rate control. J Card Fail 11 (2005) 164
28. AF-CHF Investigators. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 144 (2002) 597
29. Hagens V.E., Crijns H.J., Van Veldhuisen D.J., et al. Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control Versus Electrical Cardioversion (RACE) study. Am Heart J 149 (2005) 1106
30. Van den Berg M.P., Tuinenburg A.E., Crijns H.J., et al. Heart failure and atrial fibrillation: current concepts and controversies. Heart 77 (1997) 309
31. Benjamin E.J., Levy D., Vaziri S.M., et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271 (1994) 840
32. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442
33. Tavazzi L., Maggioni A.P., Lucci D., et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 27 (2006) 1207
34. Siirila-Waris K., Lassus J., Melin J., et al. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 27 (2006) 3011
35. Bentancur A.G., Rieck J., Koldanov R., et al. Acute pulmonary edema in the emergency department: clinical and echocardiographic survey in an aged population. Am J Med Sci 323 (2002) 238
36. Podrid P, Ganz L. Approach to the diagnosis and treatment of wide QRS complex tachycardia. Available at: www.UpToDate.com, Vol Online 15.3. Accessed October 1, 2008.
37. Zannad F., Briancon S., Juilliere Y., et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 33 (1999) 734
38. Rudiger A., Harjola V.P., Muller A., et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail 7 (2005) 662
39. Fonarow G.C., Abraham W.T., Albert N.M., et al. Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148 (2004) 43
40. O'Connor C.M., Stough W.G., Gallup D.S., et al. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 11 (2005) 200
41. Cuffe M.S., Califf R.M., Adams Jr. K.F., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287 (2002) 1541
42. VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 (2002) 1531
43. Follath F., Cleland J.G., Just H., et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360 (2002) 196
44. Torre-Amione G., Young J.B., Colucci W.S., et al. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 42 (2003) 140
45. O'Connor C.M., Gattis W.A., Adams Jr. K.F., et al. Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the randomized intravenous TeZosentan study (RITZ-4). J Am Coll Cardiol 41 (2003) 1452
46. Kaluski E., Kobrin I., Zimlichman R., et al. RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study. J Am Coll Cardiol 41 (2003) 204
47. Burger A.J., Horton D.P., LeJemtel T., et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 144 (2002) 1102
48. Gattis W.A., O'Connor C.M., Gallup D.S., et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (IMPACT-HF) trial. J Am Coll Cardiol 43 (2004) 1534
49. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. Eur Heart J 18 (1997) 649
50. Hou Z.Y., Chang M.S., Chen C.Y., et al. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone: a randomized, digoxin-controlled study. Eur Heart J 16 (1995) 521
51. Clemo H.F., Wood M.A., Gilligan D.M., et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 81 (1998) 594
52. Kumar A. Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. South Med J 89 (1996) 779
53. Andrivet P., Boubakri E., Dove P.J., et al. A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia. Eur Heart J 15 (1994) 1396
54. Goldenberg I.F., Lewis W.R., Dias V.C., et al. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure. Am J Cardiol 74 (1994) 884
55. Heywood J.T., Graham B., Marais G.E., et al. Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure. Am J Cardiol 67 (1991) 1150